• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Epidemiology and Natural History of NAFLD.非酒精性脂肪性肝病的流行病学与自然史
J Med Biochem. 2015 Jan;34(1):13-17. doi: 10.2478/jomb-2014-0049. Epub 2014 Oct 8.
2
Review article: epidemiology, pathogenesis and potential treatments of paediatric non-alcoholic fatty liver disease.综述文章:儿童非酒精性脂肪性肝病的流行病学、发病机制及潜在治疗方法
Aliment Pharmacol Ther. 2008 Jul;28(1):13-24. doi: 10.1111/j.1365-2036.2008.03703.x. Epub 2008 Apr 4.
3
Nonalcoholic Fatty liver disease/non-alcoholic steatohepatitis in childhood: endocrine-metabolic "mal-programming".儿童非酒精性脂肪性肝病/非酒精性脂肪性肝炎:内分泌代谢“编程异常”
Hepat Mon. 2014 May 1;14(5):e17641. doi: 10.5812/hepatmon.17641. eCollection 2014 May.
4
Pediatric nonalcoholic fatty liver disease: a critical appraisal of current data and implications for future research.小儿非酒精性脂肪性肝病:对当前数据的批判性评估及对未来研究的启示
J Pediatr Gastroenterol Nutr. 2006 Oct;43(4):413-27. doi: 10.1097/01.mpg.0000239995.58388.56.
5
Features of nonalcoholic steatohepatitis in severely obese children and adolescents undergoing sleeve gastrectomy.重度肥胖青少年行袖状胃切除术与非酒精性脂肪性肝炎相关特征。
Surg Obes Relat Dis. 2017 Sep;13(9):1599-1609. doi: 10.1016/j.soard.2017.04.005. Epub 2017 Apr 7.
6
The American lifestyle-induced obesity syndrome diet in male and female rodents recapitulates the clinical and transcriptomic features of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.美国生活方式引起的肥胖综合征饮食在雄性和雌性啮齿动物中再现了非酒精性脂肪性肝病和非酒精性脂肪性肝炎的临床和转录组特征。
Am J Physiol Gastrointest Liver Physiol. 2020 Sep 1;319(3):G345-G360. doi: 10.1152/ajpgi.00055.2020. Epub 2020 Aug 5.
7
Definitive diagnosis and assessment of risk for nonalcoholic fatty liver disease in children and adolescents.儿童和青少年非酒精性脂肪性肝病的确诊及风险评估
Semin Liver Dis. 2007 Aug;27(3):312-8. doi: 10.1055/s-2007-985075.
8
[Pediatric nonalcoholic fatty liver disease/nonalcoholic steatohepatitis].[小儿非酒精性脂肪性肝病/非酒精性脂肪性肝炎]
Nihon Rinsho. 2012 Oct;70(10):1827-34.
9
Similarities and differences between pediatric and adult nonalcoholic fatty liver disease.儿童与成人非酒精性脂肪性肝病之间的异同
Metabolism. 2016 Aug;65(8):1161-71. doi: 10.1016/j.metabol.2016.01.008. Epub 2016 Jan 20.
10
The Epidemiology, Risk Profiling and Diagnostic Challenges of Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病的流行病学、风险评估及诊断挑战
Medicines (Basel). 2019 Mar 18;6(1):41. doi: 10.3390/medicines6010041.

引用本文的文献

1
Increased serum carboxylesterase-1 levels are associated with metabolic dysfunction associated steatotic liver disease and metabolic syndrome in children with obesity.血清羧酸酯酶-1 水平升高与肥胖儿童代谢相关脂肪性肝病和代谢综合征相关的代谢功能障碍有关。
Ital J Pediatr. 2024 Sep 4;50(1):162. doi: 10.1186/s13052-024-01733-7.
2
Estimating utility values for non-alcoholic steatohepatitis health states: a discrete choice experiment.估算非酒精性脂肪性肝炎健康状况的效用值:一项离散选择实验。
J Comp Eff Res. 2024 Feb;13(2):e230033. doi: 10.57264/cer-2023-0033. Epub 2024 Jan 16.
3
Safety, tolerability, pharmacokinetics and pharmacodynamics of a novel farnesoid X receptor (FXR) agonist-TQA3526 in healthy Chinese volunteers: a double-blind, randomized, placebo-controlled, dose-escalation, food effect phase I study.新型法尼醇 X 受体(FXR)激动剂 TQA3526 在健康中国志愿者中的安全性、耐受性、药代动力学和药效学:一项双盲、随机、安慰剂对照、剂量递增、食物影响的 I 期研究。
Ann Med. 2023;55(2):2264850. doi: 10.1080/07853890.2023.2264850. Epub 2023 Dec 10.
4
Epidemiology and disease burden of non-alcoholic steatohepatitis in greater China: a systematic review.大中华地区非酒精性脂肪性肝炎的流行病学和疾病负担:系统评价。
Hepatol Int. 2022 Feb;16(1):27-37. doi: 10.1007/s12072-021-10286-4. Epub 2022 Jan 31.
5
Spectrum of Phenotypes and Causes of Type 2 Diabetes in Children.儿童 2 型糖尿病的表型谱及病因。
Annu Rev Med. 2022 Jan 27;73:501-515. doi: 10.1146/annurev-med-042120-012033.
6
Clinical Significance of HSPD1/MMP14/ITGB1/miR-6881-5P/Lnc-SPARCL1-1:2 RNA Panel in NAFLD/NASH Diagnosis: Egyptian Pilot Study.HSPD1/MMP14/ITGB1/miR-6881-5P/Lnc-SPARCL1-1:2 RNA检测组合在非酒精性脂肪性肝病/非酒精性脂肪性肝炎诊断中的临床意义:埃及初步研究
Biomedicines. 2021 Sep 17;9(9):1248. doi: 10.3390/biomedicines9091248.
7
The role of oxidative stress in the development of obesity and obesity-related metabolic disorders.氧化应激在肥胖及肥胖相关代谢紊乱发生发展中的作用。
J Med Biochem. 2021 Jan 26;40(1):1-9. doi: 10.5937/jomb0-24652.
8
The Effect of Autophagy on Chronic Intermittent Hypobaric Hypoxia Ameliorating Liver Damage in Metabolic Syndrome Rats.自噬对慢性间歇性低压低氧改善代谢综合征大鼠肝损伤的作用
Front Physiol. 2020 Jan 30;11:13. doi: 10.3389/fphys.2020.00013. eCollection 2020.
9
Anti-NASH Drug Development Hitches a Lift on PPAR Agonism.抗 NASH 药物研发因 PPAR 激动剂而受阻。
Cells. 2019 Dec 21;9(1):37. doi: 10.3390/cells9010037.
10
A Structured Literature Review of the Epidemiology and Disease Burden of Non-Alcoholic Steatohepatitis (NASH).非酒精性脂肪性肝炎(NASH)的流行病学和疾病负担的结构化文献综述。
Adv Ther. 2019 Jul;36(7):1574-1594. doi: 10.1007/s12325-019-00960-3. Epub 2019 May 7.

本文引用的文献

1
Influence of dietary pattern, physical activity, and I148M PNPLA3 on steatosis severity in at-risk adolescents.饮食模式、体力活动和 I148M PNPLA3 对高危青少年脂肪变性严重程度的影响。
Genes Nutr. 2014 May;9(3):392. doi: 10.1007/s12263-014-0392-8. Epub 2014 Mar 14.
2
A 4-polymorphism risk score predicts steatohepatitis in children with nonalcoholic fatty liver disease.一个四态风险评分可预测非酒精性脂肪性肝病患儿的肝炎。
J Pediatr Gastroenterol Nutr. 2014 May;58(5):632-6. doi: 10.1097/MPG.0000000000000279.
3
Serum retinol-binding protein 4 is independently associated with pediatric NAFLD and fasting triglyceride level.血清视黄醇结合蛋白 4 与儿童非酒精性脂肪性肝病及空腹甘油三酯水平独立相关。
J Pediatr Gastroenterol Nutr. 2013 Feb;56(2):145-50. doi: 10.1097/MPG.0b013e3182722aee.
4
Diagnosis of nonalcoholic fatty liver disease in children and adolescents: position paper of the ESPGHAN Hepatology Committee.儿童和青少年非酒精性脂肪性肝病的诊断:ESPGHAN 肝病委员会立场文件。
J Pediatr Gastroenterol Nutr. 2012 May;54(5):700-13. doi: 10.1097/MPG.0b013e318252a13f.
5
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: a systematic review.生活方式干预治疗成人非酒精性脂肪性肝病:系统评价。
J Hepatol. 2012 Jan;56(1):255-66. doi: 10.1016/j.jhep.2011.06.010. Epub 2011 Jul 1.
6
Non-invasive diagnosis of nonalcoholic fatty liver and nonalcoholic steatohepatitis.非酒精性脂肪性肝病和非酒精性脂肪性肝炎的无创诊断。
J Dig Dis. 2011 Feb;12(1):10-6. doi: 10.1111/j.1751-2980.2010.00471.x.
7
Epidemiology of non-alcoholic fatty liver disease.非酒精性脂肪性肝病的流行病学。
Dig Dis. 2010;28(1):155-61. doi: 10.1159/000282080. Epub 2010 May 7.
8
Pathology of nonalcoholic fatty liver disease.非酒精性脂肪性肝病的病理学。
Nat Rev Gastroenterol Hepatol. 2010 Apr;7(4):195-203. doi: 10.1038/nrgastro.2010.21. Epub 2010 Mar 2.
9
Rapid progression of NASH in childhood.儿童非酒精性脂肪性肝炎的快速进展
J Pediatr Gastroenterol Nutr. 2010 Apr;50(4):453-6. doi: 10.1097/MPG.0b013e3181a9387b.
10
Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis.随机对照试验测试减肥对非酒精性脂肪性肝炎的影响。
Hepatology. 2010 Jan;51(1):121-9. doi: 10.1002/hep.23276.

非酒精性脂肪性肝病的流行病学与自然史

Epidemiology and Natural History of NAFLD.

作者信息

Corte Claudia Della, Ferrari Federica, Villani Alberto, Nobili Valerio

机构信息

Hepato-Metabolic Department, »Bambino Gesù« Children's Hospital, Rome, Italy.

Pediatric Department, Pediatric Gastroenterology and Liver Unit, Umberto I Hospital, Sapienza University of Rome, Italy.

出版信息

J Med Biochem. 2015 Jan;34(1):13-17. doi: 10.2478/jomb-2014-0049. Epub 2014 Oct 8.

DOI:10.2478/jomb-2014-0049
PMID:28356818
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4922331/
Abstract

Paralleling the growing prevalence of obesity and metabolic syndrome, nonalcoholic fatty liver disease (NAFLD) is emerging as the most frequent hepatopathy in adults and children. The true prevalence of pediatric NAFLD is still unknown, because of the heterogeneity of diagnostic methods used for diagnosis in the available studies and the different characteristics of the populations evaluated. Pediatric NAFLD is typically of primary origin and it is strongly associated with several features of the metabolic syndrome. Age, gender and race/ethnicity are significant determinants of risk, and sex hormones, insulin sensitivity and adipocytokines are implicated in the pathogenesis of pediatric NAFLD. The natural history of NAFLD in children is still poorly understood, because of its complex nature and the scarcity of prospective studies, especially in pediatric populations. Both genetic and environmental factors seem to be implicated in the development and progression of the disease via multiple mechanisms that involve liver crosstalk with other organs and tissues, especially gut and adipose tissue. To evaluate and effectively treat pediatric NAFLD, the pathophysiology and natural history of the disease should be clarified and noninvasive methods for screening, diagnosis, and longitudinal assessment developed.

摘要

与肥胖和代谢综合征患病率不断上升相平行的是,非酒精性脂肪性肝病(NAFLD)正成为成人和儿童中最常见的肝病。由于现有研究中用于诊断的方法存在异质性以及所评估人群的不同特征,儿童NAFLD的真实患病率仍不清楚。儿童NAFLD通常为原发性,并且与代谢综合征的几个特征密切相关。年龄、性别和种族/族裔是风险的重要决定因素,性激素、胰岛素敏感性和脂肪细胞因子与儿童NAFLD的发病机制有关。由于其性质复杂且前瞻性研究稀缺,尤其是在儿科人群中,儿童NAFLD的自然病程仍知之甚少。遗传和环境因素似乎都通过多种机制参与了该疾病的发生和发展,这些机制涉及肝脏与其他器官和组织(尤其是肠道和脂肪组织)的相互作用。为了评估和有效治疗儿童NAFLD,应阐明该疾病的病理生理学和自然病程,并开发用于筛查、诊断和纵向评估的非侵入性方法。